Edition:
United States

Easywell Biomedicals Inc (1799.TWO)

1799.TWO on Gre Tai Securities Market of Chinese Taipei

21.55TWD
20 Nov 2017
Change (% chg)

NT$0.35 (+1.65%)
Prev Close
NT$21.20
Open
NT$21.20
Day's High
NT$21.55
Day's Low
NT$21.20
Volume
37
Avg. Vol
141,742
52-wk High
NT$29.60
52-wk Low
NT$20.10

Chart for

About

Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal... (more)
No analyst recommendations are available for .

Overall

Beta: 0.93
Market Cap(Mil.): NT$1,777.46
Shares Outstanding(Mil.): 83.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 51.22 15.79
EPS (TTM): -- -- --
ROI: -- 13.48 12.01
ROE: -- 20.00 15.91

BRIEF-Easywell Biomedical unit passes FDA approval

* Says its unit Magnifica Inc received approval for its long-lasting cough medicine TLX-001 from U.S Food and Drug Administration

Sep 07 2017

Earnings vs. Estimates

No consensus analysis data available.